Slides
Page 1
25 August 2026 Half-year financial report (unaudited): A pivotal period – sharpening Canatu's path to scalable growth Canatu January-June 2026 webcast
Page 2
Disclaimer Notice Canatu Plc (the “Company”) has prepared this presentation for information purposes only. For the purposes of this disclaimer, “presentation” means these slides, their contents or any part of them, any oral presentation, any question or answer session and any written or oral materials discussed or distributed during the presentation meeting. The information contained in this presentation is not for publication or distribution, directly or indirectly, in or into the United States, Canada, New Zealand, Australia, Japan, Hong Kong, Singapore, South Africa or any other jurisdiction where such publication or distribution would violate applicable laws or rules or would require additional documents to be completed or registered or require any measure to be undertaken in addition to the requirements under Finnish law. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. The information contained in this presentation does not constitute an offer of securities for sale in the United States, nor may the securities be offered or sold in the United States absent registration or an exemption from registration as provided in the U.S. Securities Act of 1933, as amended, and the rules and regulations thereunder. The Company does not intend to register any shares or other securities in the United States or to conduct a public offering of securities in the United States. This presentation does not constitute an offer of or an invitation by or on behalf of, the Company, or any other person, to issue, subscribe for, purchase or sell any securities. This presentation does not constitute a listing prospectus or a company description. You should consult the company description, prepared in accordance with the decree of the Ministry of Finance (1281/2018, as amended) on the basic information document referred to in Chapter 3, Section 2 of the Securities Markets Act (746/2012, as amended), the Nasdaq First North Growth Market Rulebook for Issuers of Shares, and other applicable regulations, and any subsequent information published by the Company for more complete information about the Company and its securities. No part of this presentation, nor the fact of its distribution, should form the basis of, or be relied on in connection with, any contract or commitment or investment decision whatsoever. This presentation contains financial information regarding the business and assets of the Company. Such financial information may not have been audited, reviewed or verified by any independent accounting firm. The information contained in this presentation has not been independently verified. No representation, warranty or undertaking, expressed or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or the opinions contained herein. The Company, nor any of its respective affiliates, advisors or representatives or any other person, shall have any liability whatsoever (in negligence or otherwise) for any loss however arising from any use of this presentation or its contents or otherwise arising in connection with this presentation. Each person must rely on their own examination and analysis of the Company and its securities, including the merits and risks involved. DNB Carnegie Investment Bank AB (publ) acts as the Company’s certified advisor. Forward-looking statements Certain statements in this presentation are “forward-looking statements”. Forward-looking statements include statements concerning plans, assumptions, projections, objectives, targets, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, the Company’s competitive strengths and weaknesses, plans or goals relating to financial position, future operations and development, its business strategy and the anticipated trends in the industry and the political and legal environment in which it operates and other information that is not historical information, such as revenue growth, EBIT growth, cost savings, investments, future cash flow generation, operating profit margin, operating capital expenditure, ratio of net debt and EBIT, revenue, and operating results. In some instances, they can be identified by the use of forward-looking terminology, including the terms “believes”, “intends”, “may”, “will” or “should” or, in each case, their negative or variations on comparable terminology. Forward-looking statements in this presentation are based on various assumptions, many of which in turn are based on assumptions. By their very nature, forward-looking statements involve inherent risks, uncertainties and assumptions, both general and specific, and the risk exists that the predictions, forecasts, projections, plans and other forward-looking statements will not be achieved. Given these risks, uncertainties and assumptions, you are cautioned not to place undue reliance on such forward-looking statements. Any information, views and forward-looking statements contained in this presentation speak only as at the date of this presentation. Save as required by law, the Company or DNB Carnegie Investment Bank AB (publ) do not intend and do not assume any obligation to update or correct any forward-looking statement contained in this presentation and do not undertake to publish such updates or corrections. 2
Page 3
AGENDA JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 3 Canatu’s new strategy H1 2026 results Q&A Mikko Vesterinen CFO Maximilian Slawinski CEO
Page 4
Where Canatu has already reached world class... Dry Deposition-based inspection membranes, touch sensors and defense sensors have been operating fault-free in the field since 2021.→ CNT-based pellicles and ADAS heaters are approaching market entry.→ Canatu has industrialized CNT property tuning and built a broad patent portfolio across critical application areas.→ Deep, long-term relationships with leading global players in the semiconductor, automotive and defense industries.→ JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 4
Page 5
Execution needs to hit commercial ambitions. ...and where Canatu needs to improve → More focus instead of many balls in the air without catching the most valuable ones.→ Investment of resources into scalable product roadmap execution instead of engineering projects. → More customer-focused than research-driven. → JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 5 More commercial metrics for development resource allocation. → POLARIS PROGRAM
Page 6
1. Planned headcount reduction of potentially up to 17 FTE in 2026 (subject to the outcome of the ongoing change negotiations)* 2. Limit of yearly CAPEX until 2030 to less than 6M€/y 3. Revenue per employee as new 2030 KPI 4. Discontinuation of low value R&D projects 1. 5 people Executive Management team ⤷ Recruitment of a CMO and CTO with strong international track record 2. New Business Development → Fellow role ⤷ Focus on IP strategy and relevant research 3. Established business development, account executive and product management functions ⤷ Accelerating productization and time-to-revenue 4. Project management responsibility transferred to CTO 5. Business Units given full project ownership 1. Clarification of business models ⤷ Semiconductor BU Inspection → product business Semi Manufacturing → equipment + IP ⤷ Robotics, Mobility & Defence BU Pure product business Clear end-markets with additional focus on robotics and defence ⤷ Medical Diagnostics BU Pure product business 2. Prioritized product roadmap based on high-value CNT applications ⤷ Refocused to highest €/cm² value 3. Stop selling engineering services New Governance New Strategy OPEX adjustment JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 6 Polaris Canatu’s transformation program *Change negotiations (FI: muutosneuvottelut) relating to the planned headcount reduction were launched on 25 August 2026 and are ongoing. The scope, timing and final number of positions affected remain subject to the outcome of these negotiations and may differ from the figures presented above.
Page 7
Innovation leadership validated First 100 days: Sharpening Canatu’s path to scalable growth 1 First 100 days delivered Strategy review completed Portfolio prioritized Business model simplified New leadership structure Building a structurally high-margin business2 Building a high-quality, scalable, recurring revenue business and a wide customer base3 100M€+ target for 2030 and vision for 20%+ CAGR high profitable growth until 20354 JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 7
Page 8
Canatu’s new Leadership Team secures efficient strategy execution JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 8 • International leadership with deep industrial experience • Stronger commercial and product focus Tapani Salminen COO Mikko Vesterinen CFO Walter Braun CTO Bernd Meier CMO Maximilian Slawinski CEO Robotics, Mobility & Defence (RMD) Medical Diagnostics Legal, General Counsel Human ResourcesSemiconductor Executive Management Business unit leaders Operational leadership
Page 9
• Scalable Dry Deposition technology platform • Strong competitive position built on differentiated, IPR- protected technology in a high-barrier-to-entry market • Operating globally, serving industry-leading customers Canatu’s DNA: Dry Deposition Technology 322 Patents granted and pending 20y+ Of technology development ~1 Million sensors delivered without issues 5,000+ Inspection membranes delivered JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 9 Semiconductor Robotics, Mobility and Defence Medical Diagnostics
Page 10
Three priorities to create shareholder value JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) Semiconductor Robotics, Mobility and Defence Medical Diagnostics Becoming a crucial supplier ⤷ Reactor + recurring revenues Scale product revenues ⤷ Product revenues Milestone-driven value generation ⤷ First product commercialization Assisted & autonomous driving Artificial Intelligence (AI) Defence Point -of-Care diagnostics Semiconductor RMD Medical Diagnostics 10
Page 11
Disciplined portfolio prioritisation drives long-term value Disciplined portfolio prioritisation drives long-term value • Focus on high-value applications • Stop low-value opportunities • Allocate capital where Canatu has competitive advantage • External engineering projects discontinued * Source: Precedence Research (total market backbone, Feb 2026), Mordor Intelligence, Market Research Future, MarketsandMarkets (automotive CAGR cross-check), TBRC, IndustryARC. Own segment estimates calibrated to total market; interim years interpolated. As of July 7, 2026. JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 11 Bubble size relative 2030 revenue (Reactor business excluded from the chart) LOW Solid HIGH VERY HIGH 5 End market CAGR (%) CNT value ADAS Heaters 3D Heater module Inspection filters Hormone testing 10 15 20 25 Semiconductor RMD MeDi Robotics and Industrial Sensing
Page 12
- 500 1,000 1,500 2,000 2,500 3,000 Wafer starts per month (1,000) Advanced-Node2 Wafer Capacity by Node3 Sub-1nm-class (~0.7nm) 1nm-class 1.4nm-class 2nm 3nm Canatu serves growing markets with long-term drivers 1) Berg Insight, McKinsey, Grand View Research, Mordor Intelligence, Goldman Sachs Research, Public information, Canatu’s own estimates 2) Advanced-Node defined as 7nm and smaller 3) SEMI, TSCM public disclosures, WSTS, Public information, Canatu’s own estimates Fully autonomous driving solutions (ADAS3+) started to penetrate the market demanding high conductive and transparent heater solutions. Driven by AI and further digitalization semiconductor device demand is not just growing but also further driving miniaturization of nodes JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 12 2nm and smaller <90% of the market by 2035, CAGR 25% 25 27 29 31 34 36 38 40 41 42 43 44 0 1 2 3 3 4 5 6 7 7 8 9 0 0 1 1 2 2 3 3 3 4 4 5 0 10 20 30 40 50 60 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 Million cars Car sales by ADAS level1 ADAS2 ADAS3 ADAS4/5 CAGR 19%
Page 13
JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 13 How the strategy translates into shareholder value 13 Illustrative representation only. FDA pathway starting CNT pellicle qualification for device manufaturing JDA with tier-1 Inspection business expansion Testosterone launch Estradiol/ progesterone launch CNT-on-wafer CNT pellicle expand to memory 3D heater launch ADAS Level 3 heater ramp Defence + Robotics expansion 2026 2030 2035 Time Revenue 100M€ 300M€ Haptics for physical AI market entry 2015 2021 2025 Automotive touch & defense sensors in mass production Inspection membranes in mass production The first CNT100 SEMI reactor received customer approval (SAT) 300M€ 100M€+ Semiconductor RMD MeDi Vision Long-term target
Page 14
Financial highlights JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 14 H1 revenue 4.2M€, long-term potential intact1 Gross margin at a good level2 Strong balance sheet – debt-free and good cash position3 Long-term financial targets 100M€+ revenue in 2030 with a minimum 20% CAGR outlook from 2030 to 2035 400k€+ revenue per employee in 2030 Less than 6M€ average annual CAPEX from 2027 onwards
Page 15
Key figures H1/26 JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 15 EUR million H1/26 H1/25 Change, % FY2025 Revenue 4.2 7.3 -42.7% 15.6 of which Semicon 0.4 5.7 -92.7% 10.8 RMD 3.6 1.6 122.7% 4.8 Medical 0.1 - NA - Gross profit 2.2 4.9 -55.2% 11.3 as percentage of revenue, % 52.7% 67.3% 72.5% Adjusted EBIT -12.6 -4.8 -159.8% -10.2 as percentage of revenue, % -300.9% -66.4% -65.3% Capital expenditure 10.5 2.2 384.2% 5.0 Net debt -70.8 -96.2 26.5% -89.9 Equity ratio, % 91.7% 94.1% 93.2% Average number of employees 174 132 31.8% 145 Personnel at the end of period 182 147 23.8% 181 • Semiconductor revenue 0.4M€. Lack of new reactor orders, and a major inspection membrane customer working down high inventory levels • RMD revenue 3.6M€ as a result of completed engineering projects • Gross margin on a good level but decreased y-o-y basis, reflecting changes in the revenue mix • Operating expenses rose with headcount, R&D activity and new premises; cost per employee stayed broadly flat • Investments in the second factory and PELMIS EUV pellicle inspection system expanded capacity and increased QC capability • Cash position and equity ratio remain strong
Page 16
Financial outlook JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 16 2026 Outlook Canatu continues to see strong long-term potential in its three business focus areas: Semiconductor, Robotics, Mobility and Defence, and Medical Diagnostics. Canatu expects that its revenue for the financial year 2026 will decline significantly compared to the revenue of 15.6M€ in the financial year 2025. In accordance with its disclosure policy, Canatu does not issue any specific numerical guidance for the financial year 2026. • In the near term, Canatu sees that there are certain factors which affect the revenue visibility and continue to increase the volatility, in the Semiconductor and Robotics, Mobility and Defence businesses. • Canatu has ongoing customer negotiations, the timing and outcome of which remain uncertain. • The commercial roll-out of ready CNT pellicles, for example, ultimately depends on Canatu’s customers’ processes and timelines. • The timeline for obtaining CNT100 SEMI reactor customer approvals is not fully within Canatu’s control, and the risk of delays cannot therefore be excluded. • The approval of operating autonomous vehicles depends on regulations implemented by local governments.
Page 17
Key takeaways 12 major changes implemented (Polaris Program)1 Full focus on profitable topline growth (CMO department)2 Must-win opportunities identified and implemented in product roadmap (CTO department & BUs)3 Building a 100M€+ revenue company by 20301 with vision to reach levels beyond 300M€ by 20352 JANUARY –JUNE 2026 | HALF -YEAR FINANCIAL REPORT (UNAUDITED) 17 1) Canatu’s long-term financial targets include the target to reach over EUR 100 million revenue in 2030 with a minimum 20% CAGR outlook fr om 2030 to 2035. 2) Canatu’s vision is to build one of the world's leading advanced CNT companies, capable of generating more than EUR 300 million in annual revenue by 2035.